Rapid Micro Biosystems (RPID) vs Sensus Healthcare (SRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sensus Healthcare (SRTS) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 13.9% versus a loss of 75.4%. Over five years, SRTS leads with a -25.6% price change compared with -94.9% for RPID. Sensus Healthcare is the larger company by market cap ($49.4 million vs $45.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RPID | SRTS |
|---|---|---|
| Share price | $0.8995 | $3.00 |
| Market cap | $45.12M | $49.39M |
| 1-day change | +4.39% | +1.01% |
| YTD return | -70.29% | -25.38% |
| 1-year return | -75.38% | -13.91% |
| 5-year return | -94.88% | -25.56% |
| EPS (TTM) | $-1.11 | $-0.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.94 | $5.49 |
| 52-week low | $0.826 | $2.66 |
| Distance from 52-week high | -81.79% | -45.36% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +539.24% | +79.33% |
| Average volume | 271.93K | 29.46K |
| Shares outstanding | 45.66M | 16.46M |
| Employees | 171 | 60 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SRTS has outperformed RPID by 61.5 percentage points over the past year.
- The two companies sit in different sectors: Rapid Micro Biosystems in Industrials and Sensus Healthcare in Health Care.
About Rapid Micro Biosystems
RPID stock →Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees
About Sensus Healthcare
SRTS stock →Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.
Health Care · Medical/Dental Instruments · 60 employees
RPID vs SRTS FAQ
Which is bigger, Rapid Micro Biosystems or Sensus Healthcare?
Sensus Healthcare (SRTS) is larger, with a market capitalization of $49.39M compared with $45.12M for Rapid Micro Biosystems (RPID).
Which stock has performed better over the past year, RPID or SRTS?
SRTS returned -13.91% over the past 12 months, compared with -75.38% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are Rapid Micro Biosystems and Sensus Healthcare in the same industry?
No. Rapid Micro Biosystems is in the Industrials sector, while Sensus Healthcare is in Health Care.